EVALUATION OF CANDIDATE VACCINE TECHNOLOGIES USING AGENT BASED COMPUTATIONAL ME
使用基于代理的计算 ME 评估候选疫苗技术
基本信息
- 批准号:7956315
- 负责人:
- 金额:$ 0.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:Biomedical ResearchClinical DataComputer Retrieval of Information on Scientific Projects DatabaseComputer SimulationComputersData CollectionDiseaseEvaluationFoundationsFundingGrantHigh Performance ComputingInstitutionModelingPopulationPublic Health SchoolsResearchResearch PersonnelResourcesSourceSupercomputingTechnologyTimeUnited States National Institutes of HealthUniversitiesVaccinesWorkbasecollegeshared memorysimulationvaccine candidate
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
This proposal seeks computational support for our recently funded Bill and Melinda Gates Foundation grant entitled Evaluation of Candidate Vaccine Technologies Using Computational Models. We have assembled a team of researchers from the Graduate School of Public Health at the University of Pittsburgh, Penn State, Imperial College, and the Pittsburgh Supercomputing Center for a unique project that will involve both clinical data collection and computational modeling to help understand how to create vaccine technologies that increase acceptance in key susceptible populations. We are here requesting computational support for the first of the four years of our project to begin the work of creating models to understand the spread of a number of candidate diseases. The support requested is for computer time on the one of the TeraGrids newest machines, Pople, the SGI Altix 4700 at the PSC. The simulations we need to perform require a large amount of shared-memory, which is a unique capability provided by this resource. Justification and estimations of the necessary computations for the upcoming year will be given, and we will also provide justification for Advanced TeraGrid support to assist us in vital aspects of our research, especially in understanding how to most effectively and efficiently use the requested resource.
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
这项提案寻求为我们最近资助的比尔和梅林达·盖茨基金会题为使用计算模型评估候选疫苗技术的赠款提供计算支持。我们召集了一个由匹兹堡大学公共卫生研究生院、宾夕法尼亚州立大学帝国理工学院和匹兹堡超级计算机中心的研究人员组成的团队,进行了一个独特的项目,该项目将涉及临床数据收集和计算建模,以帮助了解如何创建疫苗技术,提高关键易感人群的接受度。我们在这里请求为我们的项目的四年中的第一年提供计算支持,以开始创建模型以了解一些候选疾病的传播。请求的支持是在TeraGrids最新的机器之一Pople上的计算机时间,即PSC的SGI Altix 4700。我们需要执行的模拟需要大量的共享内存,这是该资源提供的独特能力。我们将为即将到来的一年提供必要计算的理由和估计,我们还将提供Advanced TeraGrid支持的理由,以帮助我们在研究的关键方面,特别是在理解如何最有效和高效地使用所请求的资源方面。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Donald H Burke其他文献
Donald H Burke的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Donald H Burke', 18)}}的其他基金
Mechanism of Microbial DNA Hypervariation through Mutagenic Transposition
通过诱变转座导致微生物 DNA 高度变异的机制
- 批准号:
10221727 - 财政年份:2018
- 资助金额:
$ 0.08万 - 项目类别:
Mechanism of Microbial DNA Hypervariation through Mutagenic Transposition
通过诱变转座导致微生物 DNA 高度变异的机制
- 批准号:
9788497 - 财政年份:2018
- 资助金额:
$ 0.08万 - 项目类别:
Mechanism of Microbial DNA Hypervariation through Mutagenic Transposition
通过诱变转座导致微生物 DNA 高度变异的机制
- 批准号:
10387714 - 财政年份:2018
- 资助金额:
$ 0.08万 - 项目类别:
Strain-specific and pan-filoviral aptamer recognition of Ebola virus glycoproteins
埃博拉病毒糖蛋白的菌株特异性和泛丝状病毒适体识别
- 批准号:
9293978 - 财政年份:2016
- 资助金额:
$ 0.08万 - 项目类别:
RNA Aptamers that Differentiate Among HIV-1 Capsid Assembly States
区分 HIV-1 衣壳组装状态的 RNA 适体
- 批准号:
9303240 - 财政年份:2016
- 资助金额:
$ 0.08万 - 项目类别:
Strain-specific and pan-filoviral aptamer recognition of Ebola virus glycoproteins
埃博拉病毒糖蛋白的菌株特异性和泛丝状病毒适体识别
- 批准号:
9181298 - 财政年份:2016
- 资助金额:
$ 0.08万 - 项目类别:
EVALUATION OF CANDIDATE VACCINE TECHNOLOGIES USING AGENT BASED COMPUTATIONAL ME
使用基于代理的计算 ME 评估候选疫苗技术
- 批准号:
8171787 - 财政年份:2010
- 资助金额:
$ 0.08万 - 项目类别:
Determinates of anti-HIV nucleic acid aptamer potency and resistance
抗HIV核酸适体效力和耐药性的测定
- 批准号:
7924282 - 财政年份:2009
- 资助金额:
$ 0.08万 - 项目类别:
Determinates of anti-HIV nucleic acid aptamer potency and resistance
抗HIV核酸适体效力和耐药性的测定
- 批准号:
7879022 - 财政年份:2009
- 资助金额:
$ 0.08万 - 项目类别:
Determinates of anti-HIV nucleic acid aptamer potency and resistance
抗HIV核酸适体效力和耐药性的测定
- 批准号:
7801719 - 财政年份:2009
- 资助金额:
$ 0.08万 - 项目类别:
相似国自然基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10934920 - 财政年份:2023
- 资助金额:
$ 0.08万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10934926 - 财政年份:2023
- 资助金额:
$ 0.08万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10945539 - 财政年份:2023
- 资助金额:
$ 0.08万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10934927 - 财政年份:2023
- 资助金额:
$ 0.08万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10945543 - 财政年份:2023
- 资助金额:
$ 0.08万 - 项目类别:
Core B-Clinical Data Collection and Management Core
核心 B-临床数据收集和管理核心
- 批准号:
10555683 - 财政年份:2023
- 资助金额:
$ 0.08万 - 项目类别:
Point-of-care prognostic modeling of PTSD risk after traumatic event exposure using digital biomarkers and clinical data from electronic health records in the emergency department setting (PREDICT)
使用数字生物标志物和急诊科电子健康记录中的临床数据对创伤事件暴露后的 PTSD 风险进行护理点预后建模 (PREDICT)
- 批准号:
10884738 - 财政年份:2023
- 资助金额:
$ 0.08万 - 项目类别:
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability
使用 CTCAE 和其他临床数据分析和解释 PRO-CTCAE,以表征药物耐受性
- 批准号:
10884103 - 财政年份:2023
- 资助金额:
$ 0.08万 - 项目类别:
THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE
NNTC 收集、存储和提供临床数据和特征明确的生物样本,包括来自研究志愿者和/或艾滋病毒感染者和艾滋病毒阴性者的器官捐献者的死后组织
- 批准号:
10934921 - 财政年份:2023
- 资助金额:
$ 0.08万 - 项目类别:
STSS TASK ORDER - NATIONAL CLINICAL DATA COLLABORATIVE (NACDAC)
STSS 任务单 - 国家临床数据协作组织 (NACDAC)
- 批准号:
10949868 - 财政年份:2023
- 资助金额:
$ 0.08万 - 项目类别:














{{item.name}}会员




